Talphera Inc. (TLPH)

[crawford2012]

AcelRx Pharmaceuticals Q4 EPS $(0.18) Beats $(0.20) Estimate, Sales $613K Miss $1.51M Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 10 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $613 thousand which missed the analyst consensus estimate of $1.51 million by 59.40 percent. This is a 17.16 percent decrease over sales of $740 thousand the same period last year.

We will see a drop in price just to spook the shareholders to sell their shares for cheap...I say let's take advantage of any dip and add more shares.

This is a great company with an excellent set of product and above all excellent leadership.

GLTA.
Crawford.